Order Article Reprints

Cambria D, Longhitano L, La Spina E, Giallongo S, Orlando L, Giuffrida R, Tibullo D, Fontana P, Barbagallo I, Nicoletti VG, et al. IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia. Life. 2023; 13(2):259. https://doi.org/10.3390/life13020259

Cambria, Daniela, Lucia Longhitano, Enrico La Spina, Sebastiano Giallongo, Laura Orlando, Rosario Giuffrida, Daniele Tibullo, Paolo Fontana, Ignazio Barbagallo, Vincenzo Giuseppe Nicoletti, and et al. 2023. "IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia" Life 13, no. 2: 259. https://doi.org/10.3390/life13020259

Cambria, D., Longhitano, L., La Spina, E., Giallongo, S., Orlando, L., Giuffrida, R., Tibullo, D., Fontana, P., Barbagallo, I., Nicoletti, V. G., Volti, G. L., Fabro, V. D., Coda, A. R. D., Liso, A., & Palumbo, G. A. (2023). IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia. Life, 13(2), 259. https://doi.org/10.3390/life13020259